World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
58
Citations
13876
World Ranking
4138
National Ranking
26

Best Publications

  • Scale for the assessment and rating of ataxia: development of a new clinical scale.

    T Schmitz-Hübsch;S Tezenas du Montcel;L Baliko;J Berciano

  • The natural history of multiple system atrophy: a prospective European cohort study

    Gregor K Wenning;Felix Geser;Felix Geser;Florian Krismer;Klaus Seppi

  • Diagnosis and treatment of Friedreich ataxia: a European perspective

    Jörg B. Schulz;Sylvia Boesch;Katrin Bürk;Alexandra Dürr

  • Clinical features of Friedreich's ataxia: Classical and atypical phenotypes

    Michael H. Parkinson;Sylvia Boesch;Wolfgang Nachbauer;Caterina Mariotti

  • Spinocerebellar ataxia types 1, 2, 3, and 6 Disease severity and nonataxia symptoms

    T Schmitz-Hübsch;M Coudert;Peter Bauer;P Giunti

  • Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry

    Martin Köllensperger;Felix Geser;Jean Pierre Ndayisaba;Sylvia Boesch

  • Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study

    Heike Jacobi;Sophie Tezenas du Montcel;Peter Bauer;Paola Giunti

  • Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy

    K. Seppi;M.F.H. Schocke;R. Esterhammer;C. Kremser

  • Red flags for multiple system atrophy

    Martin Köllensperger;Felix Geser;Klaus Seppi;Michaela Stampfer-Kountchev

  • Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).

    David R Lynch;Melanie P Chin;Martin B Delatycki;S H Subramony

  • The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study

    H. Jacobi;P. Bauer;P. Giunti;R. Labrum

  • Consensus Paper: Management of Degenerative Cerebellar Disorders

    W. Ilg;A. J. Bastian;S. Boesch;R. G. Burciu

  • Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: A cross-sectional analysis of baseline data

    Kathrin Reetz;Imis Dogan;Imis Dogan;Ana S Costa;Manuel Dafotakis

  • Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data

    Heike Jacobi;Kathrin Reetz;Kathrin Reetz;Sophie Tezenas du Montcel;Peter Bauer

  • Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients

    Tanja T. Schmitz-Hübsch;Sophie Tezenas S.T. du Montcel;Laszlo L. Baliko;Sylvia S. Boesch

  • Monogenic variants in dystonia: an exome-wide sequencing study.

    Michael Zech;Robert Jech;Sylvia Boesch;Matej Škorvánek

  • Dystonia in multiple system atrophy

    S M Boesch;G K Wenning;G Ransmayr;W Poewe

  • Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes

    Sophie Tezenas Du Montcel;Sophie Tezenas Du Montcel;Alexandra Durr;Peter Bauer;Karla P. Figueroa

  • Comparison of three clinical rating scales in Friedreich ataxia (FRDA).

    Katrin Bürk;Katrin Bürk;Ulrike Mälzig;Stefanie Wolf;Suzette Heck

  • Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6

    Christoph Globas;Sophie Tezenas du Montcel;Laslo Baliko;Syliva Boesch

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles